RAPP(RAPP)
RAPP
ANALYST COVERAGE5 analysts
BUY
▲ +36.7%upside to target
L $40.00
Med $47.00consensus
H $66.00PRICE
Prev Close
35.18
Open
35.22
Day Range33.82 – 35.79
33.82
35.79
52W Range7.73 – 42.27
7.73
42.27
77% of range
VOLUME & SIZE
Avg Volume
342.8K
FUNDAMENTALS
P/E Ratio
-13.2x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Upcoming Events
EEarnings Report
Tomorrow
May 20
DEx-Dividend
In 90 days
Aug 17
PDividend Pay
In 97 days
Aug 24
Key MetricsTTM
Market Cap$1.28B
Revenue TTM$20.00M
Net Income TTM-$107.28M
Free Cash Flow-$80.54M
Gross Margin97.5%
Operating Margin-611.0%
Net Margin-536.4%
Return on Equity-24.8%
Return on Assets-21.6%
Debt / Equity0.02
Current Ratio27.08
EPS TTM$-2.27
RAPP News
About
No description available.
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Brian CorcoranController
Steven PaulFounder & Independent Chairman
Troy A. IgnelziChief Financial Officer
Abraham N. CeesayChief Executive Officer, President, Treasurer & Director
Swamy YeleswaramChief Development Officer
Cheryl GaultChief Operating Officer
Julie DiCarloHead of Communications & Investor Relations
Karina ChmielewskiChief Information Officer & Head of Operations
David BredtFounder & Chief Scientific Officer
Jeffrey SevignyChief Medical Officer
Kathleen A. WilkinsonChief People Officer
Arnold R. GammaitoniSenior Vice President of Medical Affairs